IGC PHARMA, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- IGC PHARMA, INC. stock issued during period, value, other for the quarter ending 2026-03-31 was $0.00.
- IGC PHARMA, INC. stock issued during period, value, other for the quarter ending 2025-06-30 was $0.00.
- IGC PHARMA, INC. stock issued during period, value, other for the quarter ending 2025-03-31 was $0.00.
- IGC PHARMA, INC. stock issued during period, value, other for the quarter ending 2022-03-31 was $0.00.
- IGC PHARMA, INC. stock issued during period, value, other for fiscal 2024 was $0.00.
- IGC PHARMA, INC. stock issued during period, value, other for fiscal 2022 was -$43.00K, a 222.86% decline from fiscal 2021.
- IGC PHARMA, INC. stock issued during period, value, other for fiscal 2021 was $35.00K.
- IGC PHARMA, INC. stock issued during period, value, other for fiscal 2017 was -$7.84M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | |
| 2024-03-31 | $0.00 10-K · filed 2025-06-27 | |
| 2022-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-07 | -$43.00K 10-K · filed 2023-07-07 |
| 2021-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-14 | |
| 2021-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-01 | |
| 2021-06-30 | -$43.00K 10-Q · filed 2022-08-05 | |
| 2021-03-31 | $35.00K 10-K · filed 2022-06-23 | |
| 2018-12-31 | $1.00M 10-Q · filed 2020-02-10 | |
| 2017-03-31 | -$7.84M 10-K · filed 2018-06-21 | |
| 2014-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-14 | $40.80K 10-K · filed 2015-07-14 |
| 2013-12-31 | -$161.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-14 | |
| 2013-09-30 | $95.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-08 | |
| 2013-06-30 | $106.36K 10-Q · filed 2013-08-16 | |
| 2013-03-31 | $501.30K 10-K · filed 2014-07-15 | |
| 2012-03-31 | $2.23M 10-K · filed 2014-07-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |